# Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke

Study · id `cardio:ct-nct06316570` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06316570](<https://clinicaltrials.gov/study/NCT06316570>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06316570

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1382 participants.

## Technical summary

Registry record NCT06316570. Randomized; triple masking; primary purpose treatment. Start 2024-04-03 (actual); primary completion 2025-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1382 participants (enrolled count; ClinicalTrials.gov record NCT06316570, source copy `cardio:ctgov-nct06316570-2026-01-22`, retrieved 2026-10-31)
- Started: 2024-04-03 (actual) (ClinicalTrials.gov record NCT06316570, source copy `cardio:ctgov-nct06316570-2026-01-22`, retrieved 2026-10-31)
- Primary completion: 2025-12-31 (actual) (ClinicalTrials.gov record NCT06316570, source copy `cardio:ctgov-nct06316570-2026-01-22`, retrieved 2026-10-31)
- Completion: 2026-01-05 (actual) (ClinicalTrials.gov record NCT06316570, source copy `cardio:ctgov-nct06316570-2026-01-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06316570, source copy `cardio:ctgov-nct06316570-2026-01-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06316570-2026-01-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke
- Acronym: TAPIS
- Condition: Ischemic Stroke, Acute
- Intervention (Drug): Early Dual Antiplatelet Therapy
- Intervention (Drug): Placebo
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial (`cardio:pubmed-42114550`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor-Aspirin With Thrombolysis by Infarct Patterns in Moderate Ischemic Stroke: TAPIS Subgroup Analysis (`cardio:pubmed-42689322`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c8cb84b57e198ed5f5d4852bfc5d21611ec9d3fb4800a962b60c4278554e7f8b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
